SETD2 and neoplasm: This means that the severe cell damage induced in the tumor region via the bimodal therapy triggered tumor neo-angiogenesis as result of a cell stress response, via the mitogen-activated protein kinase (MAPK) pathway and not via the presence of HIF-1 α-positive tumor cells as usually seen in hypoxic conditions.